F. Diana Hausman's Insider Trades & SAST Disclosures

F. Diana Hausman's most recent trade in Immuneering Corp - Ordinary Shares Class A was a trade of 33,350 Stock Option done . Disclosure was reported to the exchange on June 12, 2024.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Immuneering Corp - Ordinar...
Diana F. Hausman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Jun 2024 33,350 33,350 - - Stock Option
Zentalis Pharmaceuticals Inc
Diana F. Hausman Chief Medical Officer Sale of securities on an exchange or to another person at price $ 12.62 per share. 09 May 2024 3,356 373,876 - 12.6 42,353 Common Stock
Zentalis Pharmaceuticals Inc
F. Diana Hausman Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2024 337,500 377,232 - 0 Common Stock
Zentalis Pharmaceuticals Inc
Hausman Diana F. Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2024 337,500 337,500 - - Stock Option (Right to Buy)
Immuneering Corp - Ordinar...
Diana F. Hausman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2023 17,500 17,500 - - Stock Option
Immuneering Corp - Ordinar...
Diana F. Hausman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Jun 2022 6,185 6,185 - - Stock Option
Immuneering Corp - Ordinar...
Diana F. Hausman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jan 2022 25,200 25,200 - - Stock Option
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades